As of January 22, 2025, Lonza (LONN.SW) has a market cap of $46.06 billion USD. According to our data, Lonza is ranked No.441 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $46.06 B |
7.99%
|
Dec 30, 2024 | $42.65 B |
52.64%
|
Dec 29, 2023 | $27.94 B |
-21.46%
|
Dec 30, 2022 | $35.58 B |
-40.18%
|
Dec 30, 2021 | $59.48 B |
34.60%
|
Dec 30, 2020 | $44.19 B |
62.08%
|
Dec 30, 2019 | $27.26 B |
39.91%
|
Dec 28, 2018 | $19.49 B |
-2.22%
|
Dec 29, 2017 | $19.93 B |
61.23%
|
Dec 30, 2016 | $12.36 B |
9.78%
|
Dec 30, 2015 | $11.26 B |
48.25%
|
Dec 30, 2014 | $7.59 B |
36.05%
|
Dec 30, 2013 | $5.58 B |
77.71%
|
Dec 28, 2012 | $3.14 B |
-6.78%
|
Dec 30, 2011 | $3.37 B |
-23.69%
|
Dec 30, 2010 | $4.42 B |
4.80%
|
Dec 31, 2009 | $4.21 B |
-23.91%
|
Dec 31, 2008 | $5.54 B |
-28.05%
|
Dec 31, 2007 | $7.69 B |
32.21%
|
Dec 29, 2006 | $5.82 B |
32.92%
|
Dec 30, 2005 | $4.38 B |
27.81%
|
Dec 31, 2004 | $3.43 B |
-8.16%
|
Dec 31, 2003 | $3.73 B |
-13.20%
|
Dec 31, 2002 | $4.30 B |
-6.59%
|
Dec 31, 2001 | $4.60 B |
36.12%
|
Dec 29, 2000 | $3.38 B |
9.94%
|
Dec 31, 1999 | $3.07 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Thermo Fisher Scientific
TMO
|
$220.26 B |
-0.000 M
|
USA
|
Danaher
DHR
|
$177.06 B |
-0.004 M
|
USA
|
Catalent
CTLT
|
$11.52 B |
0.000 M
|
USA
|
Charles River Laboratories
CRL
|
$8.62 B |
0.000 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$9.97 B |
1.786 B
|
USA
|
Agilent Technologies
A
|
$43.33 B |
0.000 M
|
USA
|
Merck KGaA
MRK.DE
|
$65.52 B |
46.041 B
|
Germany
|
Samsung Biologics
207940.KS
|
$50.36 B |
0.646 B
|
S. Korea
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Market Cap | = | LONN.SW Stock Price | * | LONN.SW Shares Outstanding |
= | $638.71 | * | 72.12 M | |
= | $46.06 B |